Literature DB >> 10601318

DNA fragmentation factor 45-deficient cells are more resistant to apoptosis and exhibit different dying morphology than wild-type control cells.

J Zhang1, X Wang, K E Bove, M Xu.   

Abstract

The DNA fragmentation factor 45 (DFF45) is a subunit of a heterodimeric DNase complex critical for the induction of DNA fragmentation in vitro. To understand the in vivo role of DFF45 in programmed cell death, we measured the expression of DFF45 during mouse development and compared DNA fragmentation and viability of DFF45-deficient cells with wild-type control cells after activation of apoptosis. We found that DFF45 is ubiquitously expressed throughout mouse development. Moreover, DFF45-deficient thymocytes are resistant to DNA fragmentation with in vivo dexamethasone treatment. Furthermore, primary thymocytes from DFF45 mutant mice are also more resistant to apoptosis than wild-type control cells on exposure to several apoptotic stimuli. Dying DFF45-deficient thymocytes exhibit different morphology than wild-type control cells in that they show reduced degree of chromatin condensation, absent nuclear fragmentation, intranuclear cytoplasmic invagination, and striking nuclear chromatin conglutination after release from disintegrating cells. These results indicate that DFF45 is essential during normal apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10601318     DOI: 10.1074/jbc.274.52.37450

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Identification of death receptors DR4 and DR5 in HTB-12 astrocytoma cell lines and determination of TRAIL sensitivity.

Authors:  Elenia Riddick; Shavonda Evans; Jeffrey Rousch; Ephraim Gwebu; Hirendra Nath Banerjee
Journal:  J Solid Tumors       Date:  2013-12-01

Review 2.  Cuts can kill: the roles of apoptotic nucleases in cell death and animal development.

Authors:  Jay Z Parrish; Ding Xue
Journal:  Chromosoma       Date:  2006-01-18       Impact factor: 4.316

3.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

4.  Heterogeneous nuclear ribonucleoprotein P2 is an autoantibody target in mice deficient for Mer, Axl, and Tyro3 receptor tyrosine kinases.

Authors:  Marko Z Radic; Kinjal Shah; Wenguang Zhang; Qingxian Lu; Greg Lemke; George M Hilliard
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

5.  Engineered cellular gene-replacement platform for selective and inducible proteolytic profiling.

Authors:  Charles W Morgan; Juan E Diaz; Samantha G Zeitlin; Daniel C Gray; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-23       Impact factor: 11.205

6.  Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.

Authors:  J A Hobbs; S Cho; T J Roberts; V Sriram; J Zhang; M Xu; R R Brutkiewicz
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Promotion of Caspase Activation by Caspase-9-mediated Feedback Amplification of Mitochondrial Damage.

Authors:  Alan D Guerrero; Ingo Schmitz; Min Chen; Jin Wang
Journal:  J Clin Cell Immunol       Date:  2012-08-09

8.  Endonuclease G is required for early embryogenesis and normal apoptosis in mice.

Authors:  Jianhua Zhang; Mei Dong; Lily Li; Yunxia Fan; Purnima Pathre; Jin Dong; Danwen Lou; James M Wells; Danyvid Olivares-Villagómez; Luc Van Kaer; Xiaodong Wang; Ming Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

9.  MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network.

Authors:  Jianjun Zhang; Haiyan Guo; Guanxiang Qian; Shengfang Ge; Huifeng Ji; Xiaobo Hu; Wantao Chen
Journal:  Mol Cancer       Date:  2010-08-06       Impact factor: 27.401

Review 10.  Cellular and nuclear degradation during apoptosis.

Authors:  Bin He; Nan Lu; Zheng Zhou
Journal:  Curr Opin Cell Biol       Date:  2009-09-24       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.